SCHEMBL20441153

SCHEMBL20441153

CCCCCC(=C\c1ccccc1)/C=C(\C)C(N)=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.62
▸ TDP1 Q9NUW8 1/20 0.61
▸ AKR1C3 P42330 1/20 0.42
▸ CES2 O00748 2/20 0.41
▸ CES1 P23141 2/20 0.41
▸ HTT P42858 1/20 0.40
▸ ELANE P08246 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38
▸ TUBB4B P68371 1/20 0.38
▸ TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964257 0.99 TDP1 (0.63) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424332 0.99 TDP1 (0.63) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424331 0.99 TDP1 (0.63) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424898 0.89 LMNA (0.66) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424327 0.87 TDP1 (0.71) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424326 0.87 TDP1 (0.71) LMNATDP1AKR1C3CES2CES1
SCHEMBL20441155 0.87 TDP1 (0.67) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424893 0.87 TDP1 (0.71) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424346 0.87 TDP1 (0.67) LMNATDP1AKR1C3CES2CES1
SCHEMBL20424345 0.87 TDP1 (0.67) LMNATDP1AKR1C3CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382848-B2 Compounds reducing malodour perception and the use thereof CHEMCOM S.A. (BE) 2022-07-12 — — US disclosed
EP-3573944-B1 COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF CHEMCOM SA (BE) 2022-03-02 — — EP disclosed
WO-2018138369-A1 COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF CHEMCOM S.A. (BE) 2018-08-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11382848-B2 Compounds reducing malodour perception and the use thereof OR51E2, OR10J3, SRD5A1 LMNA 4749/4885TDP1 4689/4885AKR1C3 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback